Kosmos Energy Ltd - Director/PDMR Shareholding

04/27/23 06:00 GMT

RNS Number : 6167X

Kosmos Energy Limited

27 April 2023

Kosmos Energy Ltd. (the "Company")
PDMR Shareholding

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

27 April 2023

The following Persons Discharging Managerial Responsibilities ("PDMRs") have had changes in their shareholdings of Common Shares in the Company:

PDMR	Date of transaction	No. of shares vested	No. of shares granted	No. of shares sold or withheld
Maria Moraeus Hanssen	25 April 2023	0	3,238	0
J. Michael Stice	25 April 2023	0	3,238	0
Sir John Douglas Kelso Grant	25 April 2023	0	3,238	0

The Notification of Dealing Form for each PDMR, which provides full details of the transactions outlined above, can be found below.

This notification is made in accordance with Article 19 of the EU Market Abuse Regulation.

Josh R. Marion
Vice President and Assistant Secretary

CONTACT:

Investor Relations

Jamie Buckland
+44 203 954 2831
jbuckland@kosmosenergy.com

Media Relations

Thomas Golembeski
+1-214-445-9674
tgolembeski@kosmosenergy.com

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	Maria Moraeus Hanssen
b)	Position / status	Director
c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Shares, par value $0.01 per share
b)	Nature of the transactions	3,238 restricted share units granted to the reporting person on April 25, 2023 under the Company's Long Term Incentive Plan (the "Plan") which are scheduled to vest 100% on the earlier of April 25, 2024 or the day immediately preceding the date of the Company's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
(1) Shares granted or vested
c)	Currency	USD
	Price	6.33
	Volume	3,238
	Total	20,496.54
(2) Shares sold or withheld
	Currency	USD
	Price	0
	Volume	0
	Total	0
d)	Aggregated information
	Price	6.33
	Volume	3,238
	Total	20,496.54
e)	Date of the transactions	25 April 2023
f)	Place of the transaction	NYSE

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	J. Michael Stice
b)	Position / status	Director
c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Shares, par value $0.01 per share
b)	Nature of the transactions	3,238 restricted share units granted to the reporting person on April 25, 2023 under the Plan which are scheduled to vest 100% on the earlier of April 25, 2024 or the day immediately preceding the date of the Company's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
(1) Shares granted or vested
c)	Currency	USD
	Price	6.33
	Volume	3,238
	Total	20,496.54
(2) Shares sold or withheld
	Currency	USD
	Price	0
	Volume	0
	Total	0
d)	Aggregated information
	Price	6.33
	Volume	3,238
	Total	20,496.54
e)	Date of the transactions	25 April 2023
f)	Place of the transaction	NYSE

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	Sir John Douglas Kelso Grant
b)	Position / status	Director
c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Shares, par value $0.01 per share
b)	Nature of the transactions	3,238 restricted share units granted to the reporting person on April 25, 2023 under the Plan which are scheduled to vest 100% on the earlier of April 25, 2024 or the day immediately preceding the date of the Company's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.
(1) Shares granted or vested
c)	Currency	USD
	Price	6.33
	Volume	3,238
	Total	20,496.54
(2) Shares sold or withheld
	Currency	USD
	Price	0
	Volume	0
	Total	0
d)	Aggregated information
	Price	6.33
	Volume	3,238
	Total	20,496.54
e)	Date of the transactions	25 April 2023
f)	Place of the transaction	NYSE

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHSEFEFMEDSEFL

Investors

News Release Details